<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: Roy Rutherford and the Autism Treatment and Prevention Centre</title>
	<atom:link href="http://holfordwatch.info/2009/04/10/roy-rutherford-and-the-autism-treatment-and-prevention-centre/feed/" rel="self" type="application/rss+xml" />
	<link>http://holfordwatch.info/2009/04/10/roy-rutherford-and-the-autism-treatment-and-prevention-centre/</link>
	<description>The truth about Patrick Holford, media nutritionist</description>
	<lastBuildDate>Fri, 14 Oct 2011 15:11:39 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
	<item>
		<title>By: Dore research &#8216;is rubbish&#8217;, but I still can&#8217;t tell you so &#171; Brainduck&#8217;s Weblog</title>
		<link>http://holfordwatch.info/2009/04/10/roy-rutherford-and-the-autism-treatment-and-prevention-centre/comment-page-1/#comment-27219</link>
		<dc:creator><![CDATA[Dore research &#8216;is rubbish&#8217;, but I still can&#8217;t tell you so &#171; Brainduck&#8217;s Weblog]]></dc:creator>
		<pubDate>Thu, 17 Dec 2009 16:39:34 +0000</pubDate>
		<guid isPermaLink="false">http://holfordwatch.info/?p=4103#comment-27219</guid>
		<description><![CDATA[[...] to the Dore programme, seems to have also been absent from Dore and setting up his own &#8216;Autism Treatment and Prevention Centre&#8216;. Holfordwatch also discovered that Rutherford withdrew from his supposed PhD researching [...]]]></description>
		<content:encoded><![CDATA[<p>[...] to the Dore programme, seems to have also been absent from Dore and setting up his own &#8216;Autism Treatment and Prevention Centre&#8216;. Holfordwatch also discovered that Rutherford withdrew from his supposed PhD researching [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dore Group (NZ) go under &#171; gimpy&#8217;s blog</title>
		<link>http://holfordwatch.info/2009/04/10/roy-rutherford-and-the-autism-treatment-and-prevention-centre/comment-page-1/#comment-18827</link>
		<dc:creator><![CDATA[Dore Group (NZ) go under &#171; gimpy&#8217;s blog]]></dc:creator>
		<pubDate>Thu, 16 Apr 2009 12:43:41 +0000</pubDate>
		<guid isPermaLink="false">http://holfordwatch.info/?p=4103#comment-18827</guid>
		<description><![CDATA[[...] I suspect that we will see the collapse of other Dore programmes this year, the world economy is not in good health and expensive, proprietary systems of disability support without an evidence base are likely to suffer.  I suspect the finances of Dore (UK), which Wynford Dore was astute enough to sell to Scott Quinnell early this year, might indicate another financial collapse.  This might explain why Dore&#8217;s medical director, Roy Rutherford, has been moonlighting in other areas. [...]]]></description>
		<content:encoded><![CDATA[<p>[...] I suspect that we will see the collapse of other Dore programmes this year, the world economy is not in good health and expensive, proprietary systems of disability support without an evidence base are likely to suffer.  I suspect the finances of Dore (UK), which Wynford Dore was astute enough to sell to Scott Quinnell early this year, might indicate another financial collapse.  This might explain why Dore&#8217;s medical director, Roy Rutherford, has been moonlighting in other areas. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: jonhw</title>
		<link>http://holfordwatch.info/2009/04/10/roy-rutherford-and-the-autism-treatment-and-prevention-centre/comment-page-1/#comment-18591</link>
		<dc:creator><![CDATA[jonhw]]></dc:creator>
		<pubDate>Sat, 11 Apr 2009 18:57:21 +0000</pubDate>
		<guid isPermaLink="false">http://holfordwatch.info/?p=4103#comment-18591</guid>
		<description><![CDATA[To be very charitable, AUTAP may have wanted to focus on research in children on the autistic spectrum...

Very interesting - if rather sad - article though.  Thanks very much for the link - interesting reading!]]></description>
		<content:encoded><![CDATA[<p>To be very charitable, AUTAP may have wanted to focus on research in children on the autistic spectrum&#8230;</p>
<p>Very interesting &#8211; if rather sad &#8211; article though.  Thanks very much for the link &#8211; interesting reading!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: dvnutrix</title>
		<link>http://holfordwatch.info/2009/04/10/roy-rutherford-and-the-autism-treatment-and-prevention-centre/comment-page-1/#comment-18579</link>
		<dc:creator><![CDATA[dvnutrix]]></dc:creator>
		<pubDate>Sat, 11 Apr 2009 11:17:49 +0000</pubDate>
		<guid isPermaLink="false">http://holfordwatch.info/?p=4103#comment-18579</guid>
		<description><![CDATA[It can&#039;t possibly be because of the desperately disappointing results for &lt;a href=&quot;http://jad.sagepub.com/cgi/content/abstract/12/5/394&quot; rel=&quot;nofollow&quot;&gt;Eye Q&lt;/a&gt;?&lt;blockquote&gt;A majority did not respond to omega 3/6 treatment. However, a subgroup of 26% responded with more than 25% reduction of ADHD symptoms and a drop of CGI scores to the near-normal range...A subgroup of children and adolescents with ADHD, characterized by inattention and associated neurodevelopmental disorders, treated with omega 3/6 fatty acids for 6 months responded with meaningful reduction of ADHD symptoms.&lt;/blockquote&gt;They can dress it up how they like but it is clear that there is no decent outcome if you were to use Intention to Treat - and there is no indication that one might be able to identify those children who would be responders.

Nonetheless, it is good to see it published rather than languishing in a desk drawer.

Overall, of course, this is rather sad - as the risk of sounding reductionist, it would be so useful for families if a comparatively straightforward intervention such as this were to be clinically significant.

Interesting to see an indication of the fact that children do improve and progress spontaneously.&lt;blockquote&gt;At the end of Study Period 1, 26% (9/34), all boys) in the active group and 7% (2/30, 1 boy, 1 girl) in the placebo group were clinically meaningful responders with more than 25% improvement in ADHD symptoms...&lt;/blockquote&gt;Plus, although the abstract sounds unduly positive about the outcomes, the discussion is rather more realistic before it dives off into sub-group analysis territory:&lt;blockquote&gt;Overall, this is an essentially negative study. The double-blind randomized placebo-controlled trial demonstrated that for the whole group of children and adolescents with ADHD, omega 3/6 supplementation for 3 months was not statistically superior to placebo...

A clinically meaningful response tended to be more frequent in the sugbroup of children with associated neurodevelopmental comorbidity, that is, RWD, DCD, LD, or AS, and was lacking altogether in children with ODD, depression, or anxiety diagnoses...This might tentatively be taken to mean that omega 3/6 treatment may be specifically effective for children with the phenotypie of deficits in attention, motor control, and perception...The results indicate that it may be helpful to select patients with this phenotype and reading or writing difficulties for future research trials and treatment with omega 3/6 fatty acids.&lt;/blockquote&gt;]]></description>
		<content:encoded><![CDATA[<p>It can&#8217;t possibly be because of the desperately disappointing results for <a href="http://jad.sagepub.com/cgi/content/abstract/12/5/394" rel="nofollow">Eye Q</a>?<br />
<blockquote>A majority did not respond to omega 3/6 treatment. However, a subgroup of 26% responded with more than 25% reduction of ADHD symptoms and a drop of CGI scores to the near-normal range&#8230;A subgroup of children and adolescents with ADHD, characterized by inattention and associated neurodevelopmental disorders, treated with omega 3/6 fatty acids for 6 months responded with meaningful reduction of ADHD symptoms.</p></blockquote>
<p>They can dress it up how they like but it is clear that there is no decent outcome if you were to use Intention to Treat &#8211; and there is no indication that one might be able to identify those children who would be responders.</p>
<p>Nonetheless, it is good to see it published rather than languishing in a desk drawer.</p>
<p>Overall, of course, this is rather sad &#8211; as the risk of sounding reductionist, it would be so useful for families if a comparatively straightforward intervention such as this were to be clinically significant.</p>
<p>Interesting to see an indication of the fact that children do improve and progress spontaneously.<br />
<blockquote>At the end of Study Period 1, 26% (9/34), all boys) in the active group and 7% (2/30, 1 boy, 1 girl) in the placebo group were clinically meaningful responders with more than 25% improvement in ADHD symptoms&#8230;</p></blockquote>
<p>Plus, although the abstract sounds unduly positive about the outcomes, the discussion is rather more realistic before it dives off into sub-group analysis territory:<br />
<blockquote>Overall, this is an essentially negative study. The double-blind randomized placebo-controlled trial demonstrated that for the whole group of children and adolescents with ADHD, omega 3/6 supplementation for 3 months was not statistically superior to placebo&#8230;</p>
<p>A clinically meaningful response tended to be more frequent in the sugbroup of children with associated neurodevelopmental comorbidity, that is, RWD, DCD, LD, or AS, and was lacking altogether in children with ODD, depression, or anxiety diagnoses&#8230;This might tentatively be taken to mean that omega 3/6 treatment may be specifically effective for children with the phenotypie of deficits in attention, motor control, and perception&#8230;The results indicate that it may be helpful to select patients with this phenotype and reading or writing difficulties for future research trials and treatment with omega 3/6 fatty acids.</p></blockquote>
]]></content:encoded>
	</item>
	<item>
		<title>By: BloggerT</title>
		<link>http://holfordwatch.info/2009/04/10/roy-rutherford-and-the-autism-treatment-and-prevention-centre/comment-page-1/#comment-18569</link>
		<dc:creator><![CDATA[BloggerT]]></dc:creator>
		<pubDate>Sat, 11 Apr 2009 07:03:57 +0000</pubDate>
		<guid isPermaLink="false">http://holfordwatch.info/?p=4103#comment-18569</guid>
		<description><![CDATA[Wonder why they left out this new small study also:

http://jad.sagepub.com/cgi/content/abstract/12/5/394]]></description>
		<content:encoded><![CDATA[<p>Wonder why they left out this new small study also:</p>
<p><a href="http://jad.sagepub.com/cgi/content/abstract/12/5/394" rel="nofollow">http://jad.sagepub.com/cgi/content/abstract/12/5/394</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>

